✦ LIBER ✦

Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer

✍ Scribed by Gao, Chengcheng; Ma, Tianheng; Pang, Liqun; Xie, Rui

Book ID: 125402439
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 243 KB
Volume: 9
Category: Article
ISSN: 1746-1596
DOI: 10.1186/1746-1596-9-55

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Snail is an independent prognostic predi

Snail is an independent prognostic predictor for progression and patient survival of gastric cancer

✍ Hongyong He; Weidong Chen; Xuefei Wang; Cong Wang; Fenglin Liu; Zhenbin Shen; Ji 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 706 KB

591 p53 mutation with transdominance act

591 p53 mutation with transdominance activity is an independent prognostic factor for endometrial cancer

✍ N. Sakuragi; E. Steiner; H. Koelble; T. Moriuchi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 153 KB

High expression of heparanase-2 is an in

High expression of heparanase-2 is an independent prognostic parameter for favorable survival in gastric cancer patients

✍ Zhang, Xiaogang; Xu, Shu; Tan, Qinxiang; Liu, Longgen 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 855 KB

Expression of C-erbB-2 oncoprotein in ga

Expression of C-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for C-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma

✍ Yutaka Yonemura; Itasu Ninomiya; Shigekazu Ohoyama; Hironobu Kimura; Akio Yamagu 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB 👁 2 views

High insulin-like growth factor-2 (IGF-2

High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer

✍ Robyn A. Sayer; Johnathan M. Lancaster; Jennifer Pittman; Jonathon Gray; Regina 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 239 KB

High tumor tissue concentration of plasm

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer

✍ Johanna Nordengren; Margareta Fredstorp Lidebring; Pär-Ola Bendahl; Nils Brünner 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 106 KB 👁 1 views

## Abstract Previous studies including various tumor types have shown different associations between tumor tissue levels of plasminogen activator inhibitor 2 (PAI‐2) and patient survival. High tumor tissue concentrations of PAI‐2 have been associated with good prognosis in patients with breast canc